Advancements in Hematology Analyzers: Next-Generation Technologies for Precision Diagnostics and Personalized Medicine
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Preprint |
| Publié: |
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866912762027835392 |
|---|---|
| author | Iqbal, Aahsan Khalid, Sohail Rehman, Mujeeb ur |
| author_facet | Iqbal, Aahsan Khalid, Sohail Rehman, Mujeeb ur |
| contents | Hematology analyzers are essential diagnostic and monitoring tools for detecting blood diseases. Although contemporary analyzers produce only basic insights, they are often not as detailed as required under the personalized medicine paradigm. Next-Generation Hematology Analyzers (NGHAs) are revolutionary newcomers in the field, with significant advantages over regular hematology analyzers. They provide deeper insights into cellular morphology, function, and genetic profiles. This detailed information opens up possibilities for tailor-made diagnostic and therapeutic approaches in precision medicine. This review presents some revolutionary technologies that have changed hematology analyzers and provides an overview of their limitations, basic functions, and influence on clinical practice. It focuses on the integration of state-of-the-art technologies, such as microfluidics, advanced optics, artificial intelligence, flow cytometry, and digital imaging, empowering NGHAs to improve diagnostic accuracy, rapidly detect diseases, and support flexible, targeted therapy. Hints regarding point-of-care hematology testing are also provided to discuss its implications for transforming healthcare patterns. This review highlights the data management, standardization, regulatory, and ethical challenges associated with these technologies. A review tracking the current state-of-the-art and trends for the future is provided to show how these advancements may reconfigure hematology analyzer design and act as a stepping stone for future therapeutic reforms. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2512_12248 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Advancements in Hematology Analyzers: Next-Generation Technologies for Precision Diagnostics and Personalized Medicine Iqbal, Aahsan Khalid, Sohail Rehman, Mujeeb ur Other Quantitative Biology Hematology analyzers are essential diagnostic and monitoring tools for detecting blood diseases. Although contemporary analyzers produce only basic insights, they are often not as detailed as required under the personalized medicine paradigm. Next-Generation Hematology Analyzers (NGHAs) are revolutionary newcomers in the field, with significant advantages over regular hematology analyzers. They provide deeper insights into cellular morphology, function, and genetic profiles. This detailed information opens up possibilities for tailor-made diagnostic and therapeutic approaches in precision medicine. This review presents some revolutionary technologies that have changed hematology analyzers and provides an overview of their limitations, basic functions, and influence on clinical practice. It focuses on the integration of state-of-the-art technologies, such as microfluidics, advanced optics, artificial intelligence, flow cytometry, and digital imaging, empowering NGHAs to improve diagnostic accuracy, rapidly detect diseases, and support flexible, targeted therapy. Hints regarding point-of-care hematology testing are also provided to discuss its implications for transforming healthcare patterns. This review highlights the data management, standardization, regulatory, and ethical challenges associated with these technologies. A review tracking the current state-of-the-art and trends for the future is provided to show how these advancements may reconfigure hematology analyzer design and act as a stepping stone for future therapeutic reforms. |
| title | Advancements in Hematology Analyzers: Next-Generation Technologies for Precision Diagnostics and Personalized Medicine |
| topic | Other Quantitative Biology |
| url | https://arxiv.org/abs/2512.12248 |